Decade-Long health tracking begins after Weight-Loss drug trial ends
NCT ID NCT04972721
Summary
This study follows 3,439 people for up to 10 years after they completed a weight-loss medication trial. Participants fill out health questionnaires every 6 months to track long-term outcomes like weight changes, heart health, diabetes risk, and quality of life. No medication or treatment is provided during this follow-up phase—researchers are simply observing what happens after the original trial ends.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
AngioCor Blumenau
Blumenau, Santa Catarina, 89020-430, Brazil
-
CIP Centro Integrado de Pesquisas do Hospital de Base
São José do Rio Preto, São Paulo, 15090-000, Brazil
-
CPCLIN - Centro de Pesquisas Clínicas
São Paulo, São Paulo, 01228-200, Brazil
-
CPQuali Pesquisa Clínica Ltda
São Paulo, São Paulo, 01228-000, Brazil
-
Cárdio Pulmonar da Bahia
Salvador, Estado de Bahia, 40170130, Brazil
-
Departamento de Gastroenterologia - HCFMUSP
São Paulo, São Paulo, 05403-000, Brazil
-
Eurolatino Medical Research Center
Uberlândia, Minas Gerais, 38400-500, Brazil
-
Hospital São Vicente de Paulo
Passo Fundo, Rio Grande do Sul, 99010-080, Brazil
-
Hospital do Coração do Brasil
Brasília, Federal District, 70390-700, Brazil
-
Instituto Brasil de Pesquisa Clinica
Rio de Janeiro, 20241-180, Brazil
-
Instituto Dante Pazzanese de Cardiologia
São Paulo, São Paulo, 04012-909, Brazil
-
Instituto de Pesquisa Clínica de Campinas
Campinas, São Paulo, 13060-080, Brazil
-
Instituto do Coração - HCFMUSP
São Paulo, São Paulo, 05403-000, Brazil
-
MAster Centre for Latvia
Marupes, 2167, Latvia
-
Master Centre Netherlands
Alphen aan den Rijn, 2408 AV, Netherlands
-
Master Centre for Algeria
Algiers, 16035, Algeria
-
Master Centre for Argentina
Prov. de Buenos Aires, B1636DSU, Argentina
-
Master Centre for Australia
North Sydney, New South Wales, 2060, Australia
-
Master Centre for Brazil
Säo Paulo, São Paulo, 05001-100, Brazil
-
Master Centre for Canada
Mississauga, Ontario, L4W 4XI, Canada
-
Master Centre for Denmark
Copenhagen S, 2300, Denmark
-
Master Centre for Finland
Espoo, FI-02600, Finland
-
Master Centre for Germany PMS
Mainz, 55124, Germany
-
Master Centre for Greece
Vouliagment, 16671, Greece
-
Master Centre for Ireland
Dublin, D09 X8W3, Ireland
-
Master Centre for Italy
Rome, 00144, Italy
-
Master Centre for Japan
Tokyo, 1000005, Japan
-
Master Centre for Malaysia
Selangor Darul Ehsan, Malaysia
-
Master Centre for Norway
Rud, 1309, Norway
-
Master Centre for South Africa
Sandton, Gauteng, 2146, South Africa
-
Master Centre for Sweden
Malmo, 202 15, Sweden
-
Master Centre for Tawain
Taipei, 106, Taiwan
-
Master Centre for Thailand
Bangkok, 10500, Thailand
-
Master Centre for USA
Plainsboro, New Jersey, 08536, United States
-
Master Centre for United Kingdom
Gatwick, West Sussex, RH6 0PA, United Kingdom
-
Master centre for India
Bangalore, 560001, India
-
Novo Nordisk Croatia Ltd.
Zagreb, 10 020, Croatia
-
Núcleo de Pesquisa Clínica S/S
Curitiba, Paraná, 80730-150, Brazil
Conditions
Explore the condition pages connected to this study.